Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1619
This examiner grants 16% of resolved cases
Alissa J. Prosser is an examiner in Tech Center 1600 and Art Unit 1619. She has managed 504 resolved cases with an allowance rate of 15.7 percent. This 15.7 percent rate indicates a challenging environment where a minority of applications reach a grant.
The interview lift is 11.2 percent. This figure suggests that conducting an interview is a productive strategy for increasing the likelihood of a grant, even from a low baseline. The 11.2 percent lift provides a meaningful boost to the allowance rate, making it a recommended tactic for practitioners to use during prosecution.
The median days to allowance is 1274. This timeline represents the typical duration for applications to reach a final grant. With 504 resolved cases, these metrics offer a clear view of the examiner's performance. The 1274-day median defines the expected prosecution experience for applicants in this docket.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18448174 | CELLULOSIC PARTICLE | Final Rejection | FUJIFILM Business Innovation Corp. |
| 18599717 | PERSONAL CARE COMPOSITION | Non-Final OA | The Procter & Gamble Company |
| 18127097 | Compositions Having Capsules | Final Rejection | The Procter & Gamble Company |
| 18421298 | HIGH CONCENTRATION SUSPENSION FORMULATION FOR COLD AND FLU SOFT GEL CAPSULE MEDICATIONS | Final Rejection | Bayer Healthcare LLC |
| 18691738 | SYNERGISTIC NANOMEDICINE DELIVERING TOPOISOMERASE I TOXIN (SN-38) AND INHIBITORS OF POLYNUCLEOTIDE KINASE 3'-PHOSPHATASE (PNKP) FOR ENHANCED TREATMENT OF COLORECTAL CANCER | Non-Final OA | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA |
| 18274607 | TINTED COSMETIC SUNSCREEN COMPOSITION, USE OF A TINTED COSMETIC SUNSCREEN COMPOSITION, AND PROCESS FOR MANUFACTURING A TINTED COSMETIC SUNSCREEN COMPOSITION | Final Rejection | L'OREAL |
| 18032950 | PHOTOPROTECTIVE COMPOSITION | Non-Final OA | L'OREAL |
| 17855767 | COMPOSITIONS AND METHODS FOR STYLING HAIR | Non-Final OA | L'OREAL |
| 17731809 | COMPOSITIONS COMPRISING A POLYPHENOL AND A GLYCEROLATED COMPOUND | Final Rejection | L'OREAL |
| 17218797 | PRESERVATIVE SYSTEM | Final Rejection | L'OREAL |
| 17442231 | METHOD FOR MANUFACTURING MEDICAL DEVICE | Final Rejection | TORAY INDUSTRIES, INC. |
| 18879432 | WATER-IN-OIL EMULSION COSMETIC COMPOSITION | Non-Final OA | SHISEIDO COMPANY, LTD. |
| 18043563 | COSMETIC | Final Rejection | SHISEIDO COMPANY, LTD. |
| 17785689 | SUNSCREEN COSMETIC | Final Rejection | Shiseido Company, Ltd. |
| 18290370 | WATER-BREAKING MAKEUP COSMETIC | Non-Final OA | SHIN-ETSU CHEMICAL CO., LTD. |
| 18560954 | A METHOD OF PROVIDING HIGH SPF TO A TOPICAL SURFACE OF A BODY | Final Rejection | Conopco, Inc., d/b/a UNILEVER |
| 18139740 | PERSONAL CARE COMPOSITION | Non-Final OA | Conopco, Inc., d/b/a UNILEVER |
| 17605718 | Use of Nanoparticles to Stabilize and Preserve the Bioactivity of Proteins and Peptides | Non-Final OA | University of Pittsburgh - Of the Commonwealth System of Higher Education |
| 17441869 | SURFACE-MODIFIED DOPED TITANIUM DIOXIDE NANOPARTICLES AND USES | Final Rejection | The Board of Regents of the University of Oklahoma |
| 18730907 | POLYALKYLENE OXIDE PARTICLES FOR PHARMACEUTICAL FORMULATION, MEDICINAL COMPOSITION, COMPOSITION FOR PHARMACEUTICAL FORMULATION, AND PHARMACEUTICAL FORMULATION | Non-Final OA | SUMITOMO SEIKA CHEMICALS CO., LTD. |
| 17309670 | SUGAR-COATED SOLID FORMS HAVING IMPROVED STABILITY | Non-Final OA | ROQUETTE FRERES |
| 18549200 | FRAGRANCE COMPOSITION | Final Rejection | GIVAUDAN SA |
| 18575604 | COSMETIC MAKE-UP COMPOSITION | Final Rejection | L V M H RECHERCHE |
| 18005792 | COSMETIC MAKE-UP COMPOSITION FOR THE LIPS | Non-Final OA | L V M H RECHERCHE |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy